<DOC>
	<DOCNO>NCT01250106</DOCNO>
	<brief_summary>The investigator aim test hypothesis Lactobacillus Reuteri-enriched microbiota improve insulin sensitivity glucose tolerance obese healthy obese type 2 diabetes patient improve gut hormone secretion compare finding healthy lean subject .</brief_summary>
	<brief_title>Probiotics Novel Approach Modulate Gut Hormone Secretion Risk Factors Type 2 Diabetes Complications</brief_title>
	<detailed_description>Prediabetes diabetes accompany insufficient gut hormone release , insulin resistance , insufficient insulin secretory capacity low grade systemic inflammation . Results recent animal experiment suggest ingestion probiotic influence gut microbiota composition intestinal permeability also secretion GLP-2 well insulin resistance , component metabolic syndrome diabetes development . GLP-2 secretion suggest key mediator probiotic effect mediate decreased intestine permeability bind intestinal GLP2 receptor animal study . Insulinotropic GLP-1 , reduce patient type 2 diabetes , also describe influenced gut microbiota composition . We aim test hypothesis Lactobacillus Reuteri-enriched microbiota improve insulin sensitivity glucose tolerance obese healthy obese type 2 diabetes patient improve gut hormone secretion . In prospective , double-blinded , placebo control randomized 10 week trial aim investigate metabolic immunological change relate modify gut microbiota analysing ( 1 ) gut hormone secretion , ( 2 ) insulin sensitivity glucose tolerance , ( 3 ) systemic LPS concentration immune status .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Obese subject : age 40 65 year , obesity ( BMI 3045 kg/m2 ) , nonsmoking , absence gastrointestinal disease , willingness abstain intake ferment milk product study period 8 week . Healthy control subject : nonobese ( BMI 1925 kg/m2 ) , nondiabetic subject , match age sex , nonsmoking , absence gastrointestinal disease , willingness abstain intake ferment milk product study period 8 week . pregnancy , cancer , chronic disease , antibiotic therapy , competitive athlete .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>probiotic</keyword>
	<keyword>prevention</keyword>
	<keyword>dietary intervention</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>obesity</keyword>
	<keyword>type 2 diabetes</keyword>
</DOC>